Polar Pharma India (Delisted) financials and balance sheet

BSE: 523333

Last traded ₹0.82 on 17 Sep 2013

Delisted on 5 Mar 2018.

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Polar Pharma India annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹26 Cr, year to Mar 2008A loss in 3 of the 3 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2012

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue16
  2. Materials and goods−8.5
  3. Employee costs−3.1
  4. Other expenses−5.5
  5. Operating profit−0.9
  6. Depreciation−2.3
  7. Other income+0.2
  8. One-off items0.0
  9. Finance costs−15
  10. Profit before tax−18
  11. Net profit−18

Profit and loss

Standalone, ₹ crore, years to March. A column marked with its months is a changeover year, when the company moved its year end: it is not a twelve-month year. No results on record for the year to Mar 2009.Polar Pharma India quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 20115 monthsMar 2012
Revenue from operations25.9–0.010.916.2
26.1–2.09.217.1
Materials and goods bought15.4––3.68.5
Employee costs5.0–0.81.63.1
Other expenses5.7–1.23.95.5
Operating profit before depreciation−0.2–−2.01.7−0.9
Operating margin−1.0%–−7,230.4%15.7%−5.8%
Materials, % of revenue59.5%––33.1%52.7%
Employee costs, % of revenue19.4%–2,778.9%14.9%19.0%
Other expenses, % of revenue22.1%–4,415.6%36.3%34.2%
Depreciation and amortisation2.4–2.32.22.3
Operating profit after depreciation−2.7–−4.2−0.5−3.2
Other income0.9–0.00.10.2
Finance costs5.2–11.813.315.1
Profit before one-off items and tax––−16.0−13.7−18.1
One-off items––––0.0
Profit before tax−7.0–−16.0−13.7−18.1
Tax−4.5––––
Net profit−2.6–−16.0−13.7−18.1
Net margin−9.9%–−59,181.5%−126.2%−111.9%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2010 they do not, so they are left blank.

Per share

Standalone, ₹ per share, years to March. A column marked with its months is a changeover year, when the company moved its year end: it is not a twelve-month year.

₹ per shareMar 2010Mar 20115 monthsMar 2012
Earnings per share−₹13.02−₹11.17−₹14.77
Market cap at the year end (₹ crore)3.503.122.53

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2012.

Measure3 years
Operating margin, average−3,618.1%
Net margin, average−29,646.7%